The period prevalence of double expression diffuse large B-cell lymphoma patients and its associated risk factors and treatment response in Hospital Universiti Sains Malaysia from 2004 to 2015
Background and Objective: Diffuse Large B-Cell Lymphoma (DLBCL) is a heterogeneous and complex disease. Its protein expression of MYC and BCL2 and/or BLC6 (Double Expression) is associated with poor response to standard treatment, thus poor prognosis. The aim is to determine the period prevalence o...
| मुख्य लेखक: | |
|---|---|
| स्वरूप: | थीसिस |
| भाषा: | अंग्रेज़ी |
| प्रकाशित: |
2017
|
| विषय: | |
| ऑनलाइन पहुंच: | http://eprints.usm.my/45621/ |